Bryan E. Welm
- Oncology top 2%
- Cancer Cells and Metastasis 22
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 6
- Cancer, Hypoxia, and Metabolism 4
- Biotechnology top 2%
- Molecular Biology top 5%
- Fibroblast Growth Factor Research 4
- Developmental Biology and Gene Regulation 3
- Cell Biology top 5%
-
- Immunotherapy and Immune Responses 4
-
- Mesenchymal stem cell research 4
- Estrogen and related hormone effects 3
- Co-authors
- Jeffrey M. RosenAlana L. WelmZena WerbMargaret A. GoodellKeith M. GligorichMatthew S. SigmanTejas P. PathakGuoying Wang
- Cited by
- OncologyCancer ResearchBiotechnology
- Journals
- Cancer Research (4 papers)Breast Cancer Research (3 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesSpainNorway
In The Last Decade
Bryan E. Welm
43 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 1.6k
- Cancer Research 691
- Biotechnology 235
- Molecular Biology 1.7k
- Cell Biology 267
Countries citing papers authored by Bryan E. Welm
This map shows the geographic impact of Bryan E. Welm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan E. Welm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan E. Welm more than expected).
Fields of papers citing papers by Bryan E. Welm
This network shows the impact of papers produced by Bryan E. Welm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan E. Welm. The network helps show where Bryan E. Welm may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bryan E. Welm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 10 | |
| 3 | 2022 | 22 | |
| 4 | 2022 | 9 | |
| 5 | 2021 | 23 | |
| 6 | 2021 | 26 | |
| 7 | 2020 | 43 | |
| 8 | 2020 | 22 | |
| 9 | 2020 | 10 | |
| 10 | 2018 | 7 | |
| 11 | 2018 | 57 | |
| 12 | 2015 | 9 | |
| 13 | 2012 | 73 | |
| 14 | 2012 | 19 | |
| 15 | 2010 | 40 | |
| 16 | 2010 | 7 | |
| 17 | Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. | 2003 | 68 |
| 18 | 2003 | 91 | |
| 19 | 2002 | 412 | |
| 20 | 2002 | 38 |
About Bryan E. Welm
Bryan E. Welm is a scholar working on Oncology, Cancer Research, Genetics, Biophysics and Molecular Biology, having authored 43 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (22 papers), Cancer Genomics and Diagnostics (6 papers), Fibroblast Growth Factor Research (4 papers), Immunotherapy and Immune Responses (4 papers), Mesenchymal stem cell research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Estrogen and related hormone effects (3 papers) and Developmental Biology and Gene Regulation (3 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (691 citations), Biotechnology (235 citations), Molecular Biology (1.7k citations) and Cell Biology (267 citations). Bryan E. Welm has collaborated with scholars based in United States, Spain and Norway. Frequent co-authors include Jeffrey M. Rosen, Alana L. Welm, Zena Werb, Margaret A. Goodell, Keith M. Gligorich, Matthew S. Sigman, Tejas P. Pathak, Guoying Wang, Timothy A. Graubert and Yoko S. DeRose. Their work appears in journals such as Cancer Research, Breast Cancer Research, Proceedings of the National Academy of Sciences, Developmental Biology and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.